These indicated that relative to other lung cancer types, “EGFR Wild Type/Low PD-L1 expression” NSCLC experiences more diversified epigenetic silencing of tumor suppressors, which made its carcinogenic mechanisms more complicated. This evidence concerns the gene EGFR and lung carcinoma.